当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 现金流量表

博瑞医药

(688166)

  

流通市值:151.26亿  总市值:151.26亿
流通股本:4.36亿   总股本:4.36亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金537,386,801.15223,828,389.471,170,190,718.44765,591,648.78
  收到的税费返还37,756,677.7913,707,913.244,379,598.2735,253,379.77
  收到其他与经营活动有关的现金21,177,462.9310,478,024.5639,513,792.6721,332,885.39
  经营活动现金流入小计596,320,941.87248,014,327.231,254,084,109.38822,177,913.94
  购买商品、接受劳务支付的现金200,308,286.6497,317,712.87268,726,107.01200,576,314.96
  支付给职工以及为职工支付的现金164,017,920.8172,003,923.1283,523,456.42215,274,981.42
  支付的各项税费47,005,444.4733,726,698.3663,204,256.2947,379,464.95
  支付其他与经营活动有关的现金169,759,856.36156,230,685.17313,439,478.15259,992,290.8
  经营活动现金流出小计581,091,508.28359,279,019.5928,893,297.87723,223,052.13
  经营活动产生的现金流量净额15,229,433.59-111,264,692.27325,190,811.5198,954,861.81
二、投资活动产生的现金流量:
  收回投资收到的现金40,470,270.6-53,955,10046,705,100
  取得投资收益收到的现金9,996,304.98---
  处置固定资产、无形资产和其他长期资产收回的现金净额44,644.45039,791.7119,194.42
  处置子公司及其他营业单位收到的现金净额-15,000,000--
  收到的其他与投资活动有关的现金885,334.5-36,813,484.16-
  投资活动现金流入小计51,396,554.5315,000,00090,808,375.8746,724,294.42
  购建固定资产、无形资产和其他长期资产支付的现金116,041,806.7347,521,206.67453,408,729.1363,386,304.78
  投资支付的现金171,286,512.69113,194,419.26259,944,195235,907,061.74
  支付其他与投资活动有关的现金14,508,100.43---
  投资活动现金流出小计301,836,419.85160,715,625.93713,352,924.1599,293,366.52
  投资活动产生的现金流量净额-250,439,865.32-145,715,625.93-622,544,548.23-552,569,072.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金51,800,00051,800,000399,800,000181,800,000
  其中:子公司吸收少数股东投资收到的现金51,800,00051,800,000399,800,000181,800,000
  取得借款收到的现金1,376,011,863.921,156,739,613.92895,048,100.82613,202,925.81
  收到其他与筹资活动有关的现金00245,000,000170,000,000
  筹资活动现金流入小计1,427,811,863.921,208,539,613.921,539,848,100.82965,002,925.81
  偿还债务支付的现金731,761,349.35492,688,837.58849,545,130.01549,850,506.34
  分配股利、利润或偿付利息支付的现金49,755,223.0115,806,785.52117,602,905.2892,923,459.85
  支付其他与筹资活动有关的现金46,319,032.228,951,785.5675,047,583.3128,563,030.74
  筹资活动现金流出小计827,835,604.58517,447,408.661,042,195,618.6671,336,996.93
  筹资活动产生的现金流量净额599,976,259.34691,092,205.26497,652,482.22293,665,928.88
四、汇率变动对现金及现金等价物的影响-7,508,690.51-2,267,044.22662,598.026,062,765.14
五、现金及现金等价物净增加额357,257,137.1431,844,842.84200,961,343.52-153,885,516.27
  加:期初现金及现金等价物余额955,063,274.47925,555,174.04754,101,930.95754,101,930.95
  期末现金及现金等价物余额1,312,320,411.571,357,400,016.88955,063,274.47600,216,414.68
补充资料:
  净利润64,484,440.12-36,954,239.18-
  资产减值准备3,436,773.54-17,497,638.54-
  固定资产和投资性房地产折旧76,287,216.11-139,258,006.16-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧76,287,216.11-139,258,006.16-
  无形资产摊销2,475,056.13-5,899,609.49-
  长期待摊费用摊销4,716,320.31-11,032,730.85-
  处置固定资产、无形资产和其他长期资产的损失-8,824.6-0-
  固定资产报废损失48,973.51-495,918.44-
  公允价值变动损失-18,727,936.8--13,784,762.71-
  财务费用45,849,720.74-61,995,963.86-
  投资损失3,529,898.35-19,321,426.73-
  递延所得税-12,270,482.93--31,936,944.27-
  其中:递延所得税资产减少-12,270,482.93--31,936,944.27-
    递延所得税负债增加--0-
  存货的减少27,532,827.27--5,959,032.89-
  经营性应收项目的减少-117,783,811.74-36,529,696.25-
  经营性应付项目的增加-104,439,977.25-1,790,481.75-
  现金的期末余额1,312,320,411.57-955,063,274.47-
  减:现金的期初余额955,063,274.47-754,101,930.95-
  现金及现金等价物的净增加额357,257,137.1-200,961,343.52-
公告日期2026-08-312026-04-302026-03-202025-10-31
审计意见(境内)标准无保留意见
TOP↑